Table 1.
Clinical characteristics of the subjects enrolled in the study
| N | 45 |
|---|---|
| Sex (M/F) | 31/14 |
| Age (years) | 35.73 ± 15.79 (35)a |
| Duration of illeness (days) | 47.75 ± 43.11 (30) |
| WBC counts (pre treatment) | 3770 ± 2215 (3300) |
| WBC counts (post treatment)b | 7433 ± 2813 (7150) |
| Spleen size (cm), (pre treatment) | 4.78 ± 2.81 (4) |
| Spleen size (cm), (post treatment) | 0.59 ± 1.21 (0) |
| Spleen scorec# | 2.47 ± 1.2 (2) |
a
Value in parentheses represents median values.
b
Post treatment values are from day 15 or day 30 post treatment.
c
Parasite scoring is on logarithmic scale from 0 to 6, where 0 is no parasites per 1000 microscopic fields (1000X), 1 is 1–10 parasites per 1000 fields, and 6 is >100 parasites per field.
#
Splenic scores presented are only based on patients underwent biopsy (some patients are treated based on rk39 strip test)